Prefilled Syringes Market Size by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) & Region - Global Forecast to 2025
The size of global prefilled syringes market in terms of revenue was estimated to be worth $5.6 billion in 2020 and is poised to reach $8.6 billion by 2025, growing at a CAGR of 9.0% from 2020 to 2025. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
Growth in the global market is majorly driven by the rising demand for prefilled syringes is attributed to the growing prevalence of chronic diseases, technological advancements, rising adoption of self-injecting parenteral devices, and supportive government regulations (especially needlestick legislations). In addition, growing awareness on the benefits of prefilled syringes among patients and healthcare professionals, along with the growing number of biologics and biosimilars in the pharmaceuticals market, is supporting the growth of the global market.
To know about the assumptions considered for the study, Request for Free Sample Report
Prefilled Syringes Market Dynamics
Driver: Rising target disease population
Prefilled syringes are mainly used for the treatment of chronic conditions, such as heart diseases, diabetes, and autoimmune diseases, which require patients to self-administer medications. As a result, the increasing incidence and prevalence of chronic and lifestyle diseases across the globe is a major factor contributing to the growth of the global market. Moreover, there is a growing demand for self-injection devices, considering the convenience and safety associated with their use.
Following are some of the key statistics related to the growing incidence and prevalence of chronic diseases:
- Globally, in 2019, approximately 436 million adults (prevalence 9.3%) were suffering from diabetes, and it is expected to rise to 700 million (prevalence 10.9%) by 2045. Moreover, more than 1.1 million children and adolescents are living with type 1 diabetes (Source: International Diabetes Federation)
- In 2018, total number of cancer cases globally was recorded at 18 million. Most common cases being lung, breast, and colorectum cancer with incidence rate in double digits (Source: WHO)
- According to the National Institute of Environmental Health Science, in 2017, 24 million people had a condition of autoimmune disease in the US. Moreover, 8 million people had auto-antibodies—blood molecules that indicate a person's chance of developing autoimmune disease
Restraint: Dearth of prefilled syringes with integrated safety features
Prefilled syringes provide greater patient safety by reducing the potential for inadvertent needle sticks and exposure to toxic products that can occur while drawing medication from vials. However, a significant number of needle stick injuries are associated with the use of bare prefilled syringes as compared to the ones that have integrated safety systems. As of 2019, ~500,000 injuries occur in the US annually, in which half of those (nearly 1,000 per day) occur in hospitals. Furthermore, as of 2019, ~1,000,000 injuries occurred annually in Europe. In such cases, the contaminated needle of prefilled syringes can lead to blood-borne infections, such as HIV and HCV.
Considering this, the limited market presence of prefilled syringes with integrated safety features, due to their expensive and challenging manufacturing procedure, is a major concern in the market. However, this trend is expected to change in the coming years, as the healthcare industry is laying greater emphasis on reducing the rate of needlestick injuries, which, in turn, is paving the way for the development of safety prefilled syringes.
Opportunity: Growing healthcare infrastructure across emerging markets
Emerging countries continue to suffer from insufficient healthcare funding, which adversely affects access to healthcare, quality, and, ultimately, the health status of citizens. According to the World Bank, approximately 400 million people lack access to essential healthcare services, mostly in Africa and South Asia. Furthermore, accelerating medical inflation, i.e., the cost of medical treatments and a higher prevalence of non-communicable lifestyle-related diseases such as cancer, diabetes, or cardiac syndromes, have resulted in funding gaps.
According to a report published by Geneva Association, in the last two decades, the share of total aggregate global expenditure on healthcare in GDP has increased from about 8% to almost 10%, or an estimated USD 8 trillion per annum, which is driven by the accelerating cost of medical treatment, expanding treatment options and increasing customer demands. Moreover, the Global Burden of Disease Health Financing Collaborator Network (2017) estimates that global spending on health will almost triple to USD 24 trillion by 2040 with upper-middle-income countries are estimated to show the fastest increase at an average of 5.3% per year. This growth could be attributed to continued growth in GDP and the rise of the middle class and government spending.
Challenge: Availability of cheaper alternatives
The purchase cost of prefilled syringes as compared to disposable syringes is significantly higher as a result of the high expenses involved in their manufacturing.
Traditionally, injectable were invasive and painful, which was the major reason for patients to prefer alternate routes of drug delivery, such as oral, topical, and nasal. Among the various routes of drug delivery, the oral route is the most preferred as it is easy to use, convenient, cost-effective, safe, and acceptable. Due to the abovementioned factors, the adoption of alternative drug delivery technologies is increasing across the globe. For instance, the development of alternate, cost-effective delivery methods for insulin, such as Pfizer's Exubera (inhalable insulin) and Medtronic's Veo insulin pump (inhalable insulin), is limiting the use of injectable insulin. Currently, insulin is mostly administered through injections, and thus, insulin injections form a significant market for injectable drug delivery technologies. However, the advent of inhalable insulin is expected to significantly impact the growth of this market as nasal drug delivery is pain-free and highly patient compliant. Also, the development of alternate delivery techniques for other disease indications, such as oral anemia treatment by GlaxoSmithKline and Bayer, is expected to adversely affect the growth of injectable technologies in the coming years.
By type, the safety prefilled syringes segment of prefilled syringes industry, is expected to grow at the highest CAGR during the forecast period
The safety prefilled syringes segment is expected to witness the highest growth during the forecast period primarily due to the rising geriatric population globally and availability of biological therapies for patients with chronic conditions and outsourcing of low-risk medical procedures for chronic patients alleviates some of the pressure on hospitals
Glass prefilled syringes is the largest material segment of the prefilled syringes industry
The glass prefilled syringes segment accounted for the largest share of the global industry in 2019. The large share of this segment is attributed to the significant benefits offered, such as prevention of oxygen and water vapor from interacting with drug compounds, compatibility with different filling machines, and seamless integration into pharmaceutical companies’ PFS operations.
Single-chamber prefilled syringes accounted for the largest share of the prefilled syringes industry, by design
The single-chamber prefilled syringes segment accounted for the largest share of the global industry in 2019. Market growth can largely be attributed to the significant advantages with the use of single-chamber prefilled syringes over vials, such as optimized API use with less overfill, reduced material requirements, less drug waste in clinical trials, and simple storage & disposal. Additionally, increasing adoption of self-administered parenteral drugs due to the increasing prevalence of chronic diseases and benefits offered by prefilled syringes
To know about the assumptions considered for the study, download the pdf brochure
Europe is the largest regional market for prefilled syringes
Europe is one of the major revenue-generating regions in the global market. Rising prevalence of chronic diseases, growth of the biologics and biosimilars market, technological advancements, geographical expansion by key manufacturers, aging population, and high adoption of self-injection devices are driving the demand for self-injectable prefilled syringes. are the major factors driving the growth of the global market in Europe.
Global players operating in the global prefilled syringes market are Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (US), Baxter International Inc (US), Ompi (Italy), Catalent, Inc. (US), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), Elcam Medical (Israel), YPSOMED (Switzerland), Oval Medical Technologies (UK), SHL Medical AG (Switzerland), Terumo (Japan).
Becton, Dickinson and Company (US) held the leadership position in the global market with a share of 37.2% in 2019. The company’s dominant position in this market can be attributed to its broad product portfolio of prefilled syringes, strong geographical presence, and wide customer base. The company primarily focuses on the strategy of product launch.
Scope of the Prefilled Syringes Industry:
Report Metric |
Details |
Market Revenue Size in 2020 |
$5.6 billion |
Projected Revenue Size by 2025 |
$8.6 billion |
Industry Growth Rate |
Poised to grow at a CAGR of 9.0% |
Market Driver |
Rising target disease population |
Market Opportunity |
Growing healthcare infrastructure across emerging markets |
This research report categorizes the prefilled syringes market to forecast revenue and analyze trends in each of the following submarkets:
By Type
-
Conventional Prefilled Syringes
- Disposable Prefilled Syringes
- Reusable Prefilled Syringes
- Safety Prefilled Syringes
By Material
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
By Design
- Single-Chamber Prefilled Syringes
- Dual- Chamber Prefilled Syringes
- Customized Prefilled Syringes
By Application
- Diabetes
- Rheumatoid Arthritis
- Anaphylaxis
- Cancer
- Thrombosis
- Ophthalmology
- Others
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- RoE
-
Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- RoAPAC
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
Recent Developments of Prefilled Syringes Industry:
- In October 2018, Becton, Dickinson and Company launched the BD Intevi 1mL two-step disposable autoinjector.
- In July 2020, Becton, Dickinson and Company entered into an partnership with Biomedical Advanced Research and Development Authority (BARDA) (US)
- In July 2018, Becton, Dickinson and Company acquired Teva Medical Inc. (US)
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global prefilled syringes market?
The global prefilled syringes market boasts a total revenue value of USD 8.6 billion by 2025.
What is the estimated growth rate (CAGR) of the global prefilled syringes market?
The global prefilled syringes market has an estimated compound annual growth rate (CAGR) of 9.0% and a revenue size in the region of USD 5.6 billion in 2020.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 21)
1.1 OBJECTIVES OF THE STUDY
1.2 PRODUCT DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 24)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: PREFILLED SYRINGES AND SUPPORTS MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 END USER-BASED MARKET ESTIMATION
2.2.2 REVENUE MAPPING-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: GLOBAL MARKET
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 32)
FIGURE 6 GLOBAL PREFILLED SYRINGES MARKET, BY MATERIAL, 2020 VS. 2025 (IN TERMS OF % MARKET SHARE)
FIGURE 7 GLOBAL MARKET, BY TYPE, 2016 VS. 2021 (USD BILLION)
FIGURE 8 GLOBAL MARKET, BY DESIGN, 2020 VS. 2025 (USD BILLION)
FIGURE 9 GLOBAL MARKET, BY APPLICATION, 2020 VS. 2025 (USD BILLION)
FIGURE 10 EUROPE TO COMMAND THE LARGEST SHARE OF THE GLOBAL PREFILLED SYRINGES INDUSTRY
4 PREMIUM INSIGHTS (Page No. - 36)
4.1 GLOBAL PREFILLED SYRINGES INDUSTRY OVERVIEW
FIGURE 11 RISING PREVALENCE OF AUTOIMMUNE DISORDERS IS DRIVING THE MARKET GROWTH
4.2 GLOBAL MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 12 REUSABLE PREFILLED SYRINGES SEGMENT IS EXPECTED TO DOMINATE THE MARKET BY 2025
4.3 GEOGRAPHIC ANALYSIS: GLOBAL MARKET, BY MATERIAL
FIGURE 13 ASIA PACIFIC SEGMENT TO POSSESS HIGH GROWTH RATE DURING THE FORECAST PERIOD
4.4 ASIA PACIFIC: MARKET, BY DESIGN AND COUNTRY (2020)
FIGURE 14 SINGLE-CHAMBER PREFILLED SYRINGES SEGMENT IS EXPECTED TO DOMINATE THE ASIA PACIFIC MARKET
4.5 GLOBAL PREFILLED SYRINGES INDUSTRY: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 39)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 PREFILLED SYRINGES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising target disease population
5.2.1.2 Rapid growth in generic products
5.2.1.3 Rising adoption of self-medication and digitalization
5.2.1.4 Affordable cost with increased efficiency of prefilled syringes
5.2.1.5 Technological advancements
5.2.2 RESTRAINTS
5.2.2.1 Dearth of prefilled syringes with integrated safety features
5.2.3 OPPORTUNITIES
5.2.3.1 Growing healthcare infrastructure across emerging markets
5.2.3.2 Surge of biologics and biosimilars in biopharma industry
5.2.3.3 Increasing adoption of wearable drug delivery technologies
5.2.4 CHALLENGES
5.2.4.1 Availability of cheaper alternatives
5.2.4.2 Challenges associated with manufacturing of prefilled syringes
5.2.5 REGULATORY SCENARIO
5.2.6 COVID-19 IMPACT
6 PREFILLED SYRINGES MARKET, BY TYPE (Page No. - 47)
6.1 INTRODUCTION
TABLE 1 GLOBAL PREFILLED SYRINGES INDUSTRY SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 2 GLOBAL MARKET, BY TYPE, 2019 (MILLION UNITS)
6.2 CONVENTIONAL PREFILLED SYRINGES MARKET
TABLE 3 GLOBAL MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 4 GLOBAL MARKET, BY TYPE, 2019 (MILLION UNITS)
TABLE 5 GLOBAL MARKET, SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 6 GLOBAL MARKET, BY REGION, 2019 (MILLION UNITS)
TABLE 7 GLOBAL MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
TABLE 8 GLOBAL MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
TABLE 9 GLOBAL MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
6.2.1 DISPOSABLE PREFILLED-SYRINGES MARKET
TABLE 10 GLOBAL MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 GLOBAL MARKET, BY REGION, 2019 (MILLION UNITS)
TABLE 12 GLOBAL MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
TABLE 13 GLOBAL MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
TABLE 14 GLOBAL MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
6.2.2 REUSABLE PREFILLED-SYRINGES MARKET
TABLE 15 GLOBAL SYRINGES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 16 GLOBAL SYRINGES MARKET, BY REGION, 2019 (MILLION UNITS)
TABLE 17 GLOBAL SYRINGES MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
TABLE 18 GLOBAL SYRINGES MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
TABLE 19 GLOBAL SYRINGES MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
6.3 SAFETY PREFILLED-SYRINGES MARKET
TABLE 20 GLOBAL SYRINGES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 GLOBAL SYRINGES MARKET, BY REGION, 2019 (MILLION UNITS)
TABLE 22 GLOBAL SYRINGES MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
TABLE 23 GLOBAL SYRINGES MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
TABLE 24 GLOBAL SYRINGES MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
7 PREFILLED SYRINGES MARKET, BY MATERIAL (Page No. - 58)
7.1 INTRODUCTION
TABLE 25 GLOBAL PREFILLED SYRINGES INDUSTRY SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
7.2 GLASS PREFILLED SYRINGES
TABLE 26 GLOBAL MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
7.3 PLASTIC PREFILLED SYRINGES
TABLE 27 GLOBAL MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
8 PREFILLED SYRINGES MARKET, BY DESIGN (Page No. - 62)
8.1 INTRODUCTION
TABLE 28 GLOBAL PREFILLED SYRINGES INDUSTRY SIZE, BY DESIGN, 2018–2025 (USD MILLION)
8.2 SINGLE-CHAMBER PREFILLED SYRINGES
TABLE 29 GLOBAL MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
8.3 DUAL-CHAMBER PREFILLED SYRINGES
TABLE 30 GLOBAL MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
8.4 CUSTOMIZED PREFILLED SYRINGES
TABLE 31 GLOBAL MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
9 PREFILLED SYRINGES MARKET, BY APPLICATION (Page No. - 66)
9.1 INTRODUCTION
TABLE 32 GLOBAL PREFILLED SYRINGES INDUSTRY SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
9.2 DIABETES
TABLE 33 GLOBAL MARKET FOR DIABETES, BY REGION, 2018–2025 (USD MILLION)
9.3 RHEUMATOID ARTHRITIS
TABLE 34 GLOBAL MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2018–2025 (USD MILLION)
9.4 ANAPHYLAXIS
TABLE 35 GLOBAL MARKET FOR ANAPHYLAXIS, BY REGION, 2018–2025 (USD MILLION)
9.5 CANCER
TABLE 36 GLOBAL MARKET FOR CANCER, BY REGION, 2018–2025 (USD MILLION)
9.6 THROMBOSIS
TABLE 37 GLOBAL MARKET FOR THROMBOSIS, BY REGION, 2018–2025 (USD MILLION)
9.7 OPHTHALMOLOGY
TABLE 38 GLOBAL MARKET FOR OPHTHALMOLOGY, BY REGION, 2018–2025 (USD MILLION)
9.8 OTHERS
TABLE 39 GLOBAL MARKET FOR OTHERS, BY REGION, 2018–2025 (USD MILLION)
10 PREFILLED SYRINGES MARKET, BY REGION (Page No. - 73)
10.1 INTRODUCTION
TABLE 40 GLOBAL PREFILLED SYRINGES INDUSTRY SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 41 GLOBAL MARKET, BY REGION, 2019 (MILLION UNITS)
10.2 NORTH AMERICA
TABLE 42 NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
TABLE 44 NORTH AMERICA MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
TABLE 45 NORTH AMERICA MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 46 NORTH AMERICA CONVENTIONAL PREFILLED-SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 47 NORTH AMERICA MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate the market in North America
TABLE 48 US MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 US CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Rising geriatric population to drive market growth
TABLE 50 CANADA MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 51 CANADA CONVENTIONAL PREFILLED-SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.3 EUROPE
TABLE 52 EUROPE PREFILLED SYRINGES INDUSTRY SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 53 EUROPE MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
TABLE 54 EUROPE MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
TABLE 55 EUROPE MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 56 EUROPE CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 EUROPE MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany to dominate the market in Europe
TABLE 58 GERMANY MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 59 GERMANY CONVENTIONAL PREFILLED-SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.3.2 UK
10.3.2.1 Growing number of CVD and diabetes patients to drive market growth
TABLE 60 UK MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 UK CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing needlestick injuries and high adoption of self-administration to drive market growth
TABLE 62 FRANCE PREFILLED SYRINGES INDUSTRY SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 63 FRANCE CONVENTIONAL PREFILLED-SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Growing focus of pharmaceutical and medical device companies on development of prefilled syringes to aid market growth
TABLE 64 ITALY MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 ITALY CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 High cancer and diabetes prevalence to drive the market
TABLE 66 SPAIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 67 SPAIN CONVENTIONAL PREFILLED-SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.3.6 REST OF EUROPE (ROE)
TABLE 68 ROE MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 ROE CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.4 ASIA PACIFIC
TABLE 70 ASIA PACIFIC PREFILLED SYRINGES INDUSTRY SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 71 ASIA PACIFIC MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
TABLE 72 ASIA PACIFIC MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
TABLE 73 ASIA PACIFIC MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 74 ASIA PACIFIC CONVENTIONAL PREFILLED-SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 75 ASIA PACIFIC MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Growing R&D activities and localized manufacturing are expected to drive market growth
TABLE 76 CHINA MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 77 CHINA CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.4.2 INDIA
10.4.2.1 Growing cancer rate and heart diseases to drive the market
TABLE 78 INDIA MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 79 INDIA CONVENTIONAL PREFILLED-SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 Growing demand for self-injection technologies to drive the market
TABLE 80 JAPAN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 81 JAPAN CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.4.4 SOUTH KOREA
10.4.4.1 Rising R&D activities focused on prefilled syringes are driving the market
TABLE 82 SOUTH KOREA PREFILLED SYRINGES INDUSTRY SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 83 SOUTH KOREA CONVENTIONAL PREFILLED-SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Growing healthcare expenditure and infrastructure to aid market growth
TABLE 84 AUSTRALIA MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 AUSTRALIA CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 86 ROAPAC MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 87 ROAPAC CONVENTIONAL PREFILLED-SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.5 LATIN AMERICA
TABLE 88 LATIN AMERICA MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 89 LATIN AMERICA MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
TABLE 90 LATIN AMERICA MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
TABLE 91 LATIN AMERICA MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 LATIN AMERICA CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 93 LATIN AMERICA MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Brazil accounted for the largest share of the Latin American market
TABLE 94 BRAZIL MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 95 BRAZIL CONVENTIONAL PREFILLED-SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Growing drug delivery market to support growth
TABLE 96 MEXICO PREFILLED SYRINGES INDUSTRY SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 MEXICO CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.5.3 REST OF LATIN AMERICA (ROLA)
TABLE 98 ROLA MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 ROLA CONVENTIONAL PREFILLED-SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
TABLE 100 MIDDLE EAST & AFRICA MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
TABLE 101 MIDDLE EAST & AFRICA MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
TABLE 102 MIDDLE EAST & AFRICA MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 MIDDLE EAST & AFRICA CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 MIDDLE EAST & AFRICA MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 103)
11.1 OVERVIEW
FIGURE 17 KEY DEVELOPMENTS IN THE PREFILLED-SYRINGES MARKET FROM 2017 TO 2020
11.2 GLOBAL MARKET SHARE ANALYSIS (2019)
FIGURE 18 BECTON, DICKINSON AND COMPANY HELD THE LEADING POSITION IN THE GLOBAL MARKET IN 2019
11.3 COMPETITIVE SCENARIO (2017 – 2020)
FIGURE 19 MAJOR COMPANIES FOCUSES ON MARKET EXPANSIONS TO MAINTAIN ITS HIGH MARKET SHARE AND TO BUILD ITS COMPETITIVE ADVANTAGE
11.3.1 KEY PRODUCT LAUNCHES (2017-20120)
11.3.2 KEY EXPANSIONS (2017-2020)
11.3.3 KEY MERGERS AND ACQUISITIONS (2017-2020)
11.3.4 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017-2020)
12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 108)
12.1 COMPANY EVALUATION MATRIX DEFINITIONS AND METHODOLOGY
12.1.1 VENDOR INCLUSION CRITERIA
12.1.1.1 Star
12.1.1.2 Emerging Leader
12.1.1.3 Pervasive
12.1.1.4 Emerging companies
FIGURE 20 PREFILLED SYRINGES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
12.2 COMPANY PROFILES
12.2.1 GERRESHEIMER AG
FIGURE 21 COMPANY SNAPSHOT: GERRESHEIMER AG
12.2.2 SCHOTT AG
FIGURE 22 COMPANY SNAPSHOT: SCHOTT AG
12.2.3 BECTON, DICKINSON AND COMPANY
FIGURE 23 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY
12.2.4 WEST PHARMACEUTICAL SERVICES, INC.
FIGURE 24 COMPANY SNAPSHOT: WEST PHARMACEUTICAL SERVICES, INC.
12.2.5 VETTER PHARMA INTERNATIONAL GMBH
12.2.6 WEIGAO GROUP
FIGURE 25 COMPANY SNAPSHOT: WEIGAO GROUP
12.2.7 OMPI (A STEVANATO GROUP COMPANY)
12.2.8 CATALENT, INC.
FIGURE 26 COMPANY SNAPSHOT: CATALENT, INC.
12.2.9 NIPRO CORPORATION
FIGURE 27 COMPANY SNAPSHOT: NIPRO CORPORATION
12.2.10 BAXTER INTERNATIONAL INC.
FIGURE 28 COMPANY SNAPSHOT: BAXTER INTERNATIONAL, INC.
12.2.11 ELCAM MEDICAL
12.2.12 YPSOMED
FIGURE 29 COMPANY SNAPSHOT: YPSOMED
12.2.13 OVAL MEDICAL TECHNOLOGIES LTD.
12.2.14 SHL MEDICAL AG
12.2.15 TERUMO CORPORATION
FIGURE 30 COMPANY SNAPSHOT: TERUMO CORPORATION
12.2.16 OTHER COMPANIES
12.2.16.1 Haselmeier
12.2.16.2 Micsafe
12.2.16.3 Dätwyler Holding Inc.
12.2.16.4 Owen Mumford Ltd
12.2.16.5 MedXL Inc.
13 APPENDIX (Page No. - 142)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
The study involved four major activities to estimate the current size of the prefilled syringes market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources, such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the orthopedic braces and supports market study.
Primary Research
The global market comprises several stakeholders such as research & academic institutions, technicians & general physicians, nurses, pharmacists, e-commerce government agencies, and research organizations. The demand side of this market is characterized by the increasing rising target disease population and increasing geriatric population globally. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is the breakdown of primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the prefilled syringes market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
To know about the assumptions considered for the study, download the pdf brochure
Data Triangulation
After arriving at the overall market size—using the market size estimation processes as explained above—the prefilled syringes market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the orthopedic braces and supports industry.
Report Objectives
- To define, describe, and forecast the prefilled syringes market by type, material, design, application, and region
- To provide detailed information about major factors influencing market growth (key drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and their contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the market value of various segments and subsegments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players active in the global market and comprehensively analyze their global revenue shares and core competencies
- To track and analyze competitive market-specific developments such as product approvals & commercialization, agreements, partnerships, collaborations, acquisitions, and expansions in the global market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the prefilled syringes market report:
Product Analysis
- Product Matrix, which gives a detailed comparison of the product portfolios of the top five global players
Product Analysis
- Further breakdown of the Rest of Europe prefilled syringes market into Russia, Portugal, Belgium, Denmark, and Switzerland, and other European countries (aggregated)
Company Information
- Detailed analysis and profiling of additional market players (up to 5 OEMs)
Growth opportunities and latent adjacency in Prefilled Syringes Market